MissionIR Articles
Original content written and distributed as part of our ongoing relationships.
-
Commodities in Bull Market Mode
In the last month or so, commodities have been on a bull run. The Standard and Poor’s GSCI gauge of 24 raw materials has jumped about 24 percent from this year’s lowest close of 559…
-
Last Intermediate Review Completed for Celsion Corp. (CLSN) Phase III HEAT Study of ThermoDox for Treating Primary Liver Cancer
Leading oncology drug development company Celsion Corporation has announced that the independent Data Monitoring Committee (DMC) for its HEAT Study has completed a regularly scheduled review of the 701 patients enrolled in the trial and…
-
Golden Minerals Company (AUMN) Secures Key Equity Financing to Support Throughput Upgrades at Mexican Silver Projects
Golden Minerals, the rapidly emerging junior silver producer with primary producing operations in Mexico and secondary evaluation stage projects in northwestern Argentina (as well as numerous exploration targets in Mexico and South America), reported today…
-
Cover-All Technologies, Inc. (COVR) Gets $2.25 Million Credit Facility from Imperium Partners to Fund Growth and Expansion
Cover-All Technologies said today that the Imperium Commercial Finance Master Fund LP, an affiliate of Imperium Partners, has agreed to provide COVR with a $2.25 million credit facility which will help COVR grow and expand.…
-
GlobalWise Investments, Inc. (GWIV) Business Strategy Based On a Marriage of Technologies
When GlobalWise Investments recently announced that it had entered into a new Channel Sales Partnership arrangement with major independent office equipment dealer RJ Young, recognized by Office Dealer magazine as one of the country’s 50…
-
Valley High Mining Co. (VHMC) Signs Machacala Joint Venture Agreement
Valley High Mining is a precious metals exploration and development company. Its focus is on lower risk precious metal opportunities and recently the company has completed its due diligence on two projects in Peru which…
-
Sonus Networks, Inc. (SONS) Announces Expanded Roles of Executive Officers to Drive Transformation
Sonus Networks announced the expanded roles of two Executive Officers, Todd A. Abbott and Jeffrey M. Snider. The roles will support the company’s next phase of transformation and execution of strategy. The roles will be…
-
Positive Results Announced for BioDelivery Sciences’ (BDSI) Pharmacokinetic Study Comparing BEMA Buprenorphine/Naloxone (BNX) to Suboxone
BioDelivery Sciences International announced a positive outcome for the company’s pharmacokinetic study of BEMA Buprenorphine/Naloxone (BNX). BNX is being developed for the potential treatment of opioid dependence and utilizes the company’s patented BioErodible MucoAdhesive (BEMA)…
-
Cytori Therapeutics, Inc. (CYTX) Announces Japanese Cell Therapy Study for Peripheral Artery Disease
Cytori Therapeutics is a company developing cell therapies based on autologous adipose-derived regenerative cells (ADRCs) to cardiovascular disease and repair soft tissue defects. The company’s therapies are made available through its proprietary device, the Cellution…
-
RiT Technologies Ltd. (RITT) Intelligent Infrastructure Management Hardware Enters Final Stage of Development
RiT Technologies announced today that its new hardware family, PV+, has entered the final stage of development. The PV+ product family is designed to support interconnect, as well as cross-connect network topologies using distinctive dual-wire…
-
Prana Biotechnology Ltd. (PRAN) Receives Approval to Proceed with Alzheimer’s Clinical Trial
Yesterday, Prana Biotechnology announced that the company had received a recommendation that it should proceed as planned in its IMAGINE clinical trial (using PBT2) for Alzheimer’s. This recommendation came from the Data Safety Monitoring Board,…
-
TheStreet, Inc. (TST) Completes Acquisition of The Deal LLC
Leading digital financial media company, TheStreet, announced that it has acquired The Deal LLC from Wasserstein & Co. Founded in 1999, The Deal LLC is a digital subscription platform that delivers coverage of the deal…
-
ModusLink Global Solutions, Inc. (MLNK) Forges Collaborative Agreement with PagBrasil, Expands e-Commerce Support to Brazil
ModusLink Global Solutions has announced a collaboration with PagBrasil to provide e-commerce transaction support in Brazil. Payment options and tax issues are complex in that country, but with this new agreement ModusLink will be able…
-
Vimicro International Corp. (VIMC) Enters Joint Venture in Shanxi Province to Expand Security-Surveillance Business
Vimicro International said today it has entered a joint venture with Shanxi Guoxin Investment Corp. (“Guoxin Group”) to form a subsidiary that will make and sell Surveillance Video and Audio Coding (“SVAC”) based security products…
-
Transcept Pharmaceuticals, Inc. (TSPT) Finishes Patient Enrollment in Phase 2 Trial of TO-2061
Transcept Pharmaceuticals is a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience. One such product in the company’s pipeline is TO-2061,…
-
Altairnano, Inc. (ALTI) and Shenhua Science & Technology Sign Memorandum of Understanding
It was recently announced that an agreement was signed by three parties to develop, deploy, and promote industrial applications of lithium titanate-based energy storage systems in China. Altairnano, Shenhua Science & Technology (Shenhua S&T) and…
-
Gilat Satellite Networks Ltd. (GILT) Subsidiary Installs VSAT Technology in 10,000th Dollar General Store
Gilat Satellite Networks, a global leader in satellite networking technology, solutions, and services, announced today that Spacenet, Inc., a wholly owned subsidiary of Gilat and prominent provider of managed network and data security services, has…
-
SFDA Approval Granted for Dehaier Medical Ltd. (DHRM) DHR-CPAP-C5 Device for Treating Sleep Apnea
Dehaier Medical Systems announced that it has obtained State Food and Drug Administration approval for DHR-CPAP-C5, one of the company’s primary proprietary homecare medical devices. The validity period for the SFDA approval is four years.…
-
Lexicon Pharmaceuticals, Inc. (LXRX) Video Chart for Wednesday, September 12, 2012
LXRX has been holding a steady uptrend throughout 2012. After a recent pullback from highs of $3.28, the chart is on the incline again and testing the 50-day moving average as the indicators show a…
-
Extensive Medical Industry Experience Links Cardium Therapeutics, Inc. (CXM) Management Team
Cardium Therapeutics, a San Diego based health sciences and regenerative medicine company, is focused on the acquisition and development of new and innovative bio-medical product opportunities and businesses offering the potential of addressing significant unmet…
-
Adherex Technologies, Inc. (AHX) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference
Adherex Technologies, a biopharmaceutical company dedicated to the discovery and development of novel cancer therapeutics, aims to increase the longevity and improve the quality of life for cancer patients. The company is developing Eniluracil, an…
-
NeuroMetrix, Inc. (NURO) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference
NeuroMetrix is a medical device company that develops and markets home use and point-of-care devices, associated consumables, and support software for the treatment and management of diabetes and its complications. The company markets the NC-stat®…
-
Amorfix Life Sciences Ltd. (AMF) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference
Amorfix Life Sciences is a theranostics company developing therapeutic products and diagnostic devices targeting misfolded protein diseases including ALS, cancer and Alzheimer’s disease. AMF currently offers four types of products: therapeutics, diagnostic kits, diagnostic services…
-
Sernova Corp. (SVA) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference
Sernova is a clinical stage health-sciences company focused on commercializing medical technologies. The company is currently developing a platform technology for a number of serious disease indications, starting with a novel treatment for insulin-dependent diabetes,…
-
Allon Therapeutics, Inc. (NPC) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference
Allon Therapeutics is a clinical-stage biotechnology company focused on innovative central nervous system therapies. NPC’s lead drug davunetide is currently in a fully enrolled pivotal phase 2/3 clinical trial in an orphan indication, progressive supranuclear…
-
Cellceutix Corp. (CTIX) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference
Cellceutix is an emerging biopharmaceutical company focused on the development of its pipeline of compounds targeting areas of unmet medical need. CTIX’ flagship compound is Kevetrin™, an anti-cancer drug. The company also owns the rights…
-
iBio, Inc. (IBIO) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference
iBio develops and offers product applications of its iBioLaunch™ platform, which provides collaborators full support for turn-key implementation of the company’s technology for both proprietary and biosimilar products. IBIO’s iBioLaunch platform is a proprietary, transformative…
-
MRI Interventions, Inc. (MRIC) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference
MRI Interventions creates innovative platforms for performing minimally invasive surgical procedures in the brain and heart. By utilizing a hospital’s existing MRI suite, MRIC’s FDA-cleared ClearPoint® system is designed to enable a range of minimally…
-
AtheroNova, Inc. (AHRO) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference
AtheroNova operates through its wholly owned subsidiary, AtheroNova Operations Inc., as an early stage biotech company focused on the discovery, research, development and licensing of novel compounds to reduce or regress atherosclerotic plaque deposits. AHRO…
-
Echo Therapeutics, Inc. (ECTE) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference
Echo Therapeutics is a transdermal medical device company specializing in advanced skin permeation technology. ECTE is developing its Prelude® SkinPrep System as a platform technology to allow for significantly enhanced and painless skin permeation that…
-
Gasco Energy, Inc. (GSX) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference
Gasco Energy is an independent oil and gas company engaged in the development of large natural gas deposits in the U.S. Rocky Mountain region and on exploratory oil plays in the San Joaquin Basin in…
-
ACADIA Pharmaceuticals, Inc. (ACAD) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference
ACADIA Pharmaceuticals is a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervous system disorders. The company’s pipeline of product includes pimavanserin, which is in phase 3…
-
Immunovaccine, Inc. (IMV) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference
Immunovaccine is a clinical stage vaccine development company focused on advancing its patented DepoVax™ vaccine adjuvanting platform and product candidates for cancer therapy and infectious diseases. The company’s pre-clinical stage vaccine product candidates comprise pandemic…
-
Verisante Technology, Inc. (VRS) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference
Verisante Technology produces coated papers, including coated groundwood and coated freesheet, and specialty paper products, for use primarily in media and marketing applications, including magazines, catalogs and commercial printing applications such as high-end advertising brochures,…
-
Hemispherx Biopharma, Inc. (HEB) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference
Hemispherx Biopharma is a specialty pharmaceutical company engaged in the manufacture and clinical development of new drug entities for treatment of seriously debilitating disorders. The company’s flagship products include Alferon N Injection(R) (FDA approved for…
-
MediciNova, Inc. (MNOV) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference
MediciNova is a biopharmaceutical company focused on acquiring and developing novel, small-molecule therapeutics for the treatment of diseases with unmet need with a commercial focus on the U.S. market. MNOV’s portfolio of clinical and preclinical…
-
Reed’s, Inc. (REED) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference
Reed’s manufactures natural sodas in the natural foods industry. The company owns the Virgil’s Root Beer product line and the China Cola product line, and in 2012 launched Reed’s Culture Club Kombucha line of organic…
-
Cytosorbents Corp. (CTSO) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference
Cytosorbents is a therapeutic device company that uses blood purification to modulate the immune system and fight multi-organ failure in life-threatening illnesses. In 2011, the company’s CytoSorb® was approved in the European Union as a…
-
Local.com Corp. (LOCM) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference
Local.com is a national online media company that connects merchants and consumers. Leveraging its technology platforms, the company provides business solutions such as digital marketing products and tools such as local business and product search,…
-
World Energy Solutions, Inc. (XWES) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference
World Energy Solutions is an energy management services firm providing a range of energy management solutions to commercial and industrial businesses, institutions, utilities and governments. The company primarily focuses on retail and wholesale energy procurement…
Search Articles
Latest Articles
- SuperCom Ltd. (NASDAQ: SPCB) U.S. Expansion Positions Company as Strong Investment Opportunity in Expanding Electronic Monitoring (‘EM’) Market
- Datavault AI Inc. (NASDAQ: DVLT) Is ‘One to Watch’
- MissionIRNewsBreaks – Wearable Devices Ltd. (NASDAQ: WLDS, WLDSW) Announces $4 Million Registered Direct Offering Priced at Market
- HeartBeam Inc. (NASDAQ: BEAT) Advances Power of ECG with High-Fidelity At-Home Heart-Monitoring System
- GlobalTech Corporation (GLTK): Building Value Through AI, Big Data, and Digital Infrastructure